Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002;15:145-154.
Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis. 1995;21(suppl 1):S57-S61.
Farthing MJ. Clinical aspects of human cryptosporidiosis. In: Petry F, ed. Cryptosporidiosis and microsporidiosis. Contributions in microbiology. Karger, Basel: 2000;6:50-74.
MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995;21:57-62.
Centers for Disease Control and Prevention. Cryptosporidiosis (Cryptosporidium spp.): 2012 case definition. February 2015. http://cdc.gov (last accessed 11 August 2017).
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001;184:103-106.
Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. December 2016. https://aidsinfo.nih.gov (last accessed 11 August 2017).
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. August 2017. http://aidsinfo.nih.gov/ (last accessed 11 August 2017).
1. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002;15:145-154.
2. Chalmers RM, Davies AP. Mini-review: Clinical cryptosporidiosis. Exp Parasitol. 2010;121:138-146.
3. Barta JR, Thompson RC. What is Cryptosporidium? Reappraising its biology and phylogenetic affinities. Trends Parasitol. 2006;22:463-468.
4. Fayer R. Taxonomy and species delimitation in Cryptosporidium. Exp Parasitol. 2010;124:90-97.
5. Chalmers RM, Robinson G, Elwin K, et al. Cryptosporidium sp. rabbit genotype, a newly identified human pathogen. Emerg Infect Dis. 2009;15:829-830.
6. Cama VA, Bern C, Roberts J, et al. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis. 2008;14:1567-1574.
7. Manabe YC, Clark DP, Moore RD, et al. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis. 1998;27:536-542.
8. Pettoello-Mantovani M, Di Martino L, Dettori G, et al. Asymptomatic carriage of intestinal Cryptosporidium immunocompetent and immunodeficient children: a prospective study. Pediatr Infect Dis J. 1995;14:1042-1047.
9. Isaacs D, Hunt GH, Phillpis AD, et al. Cryptosporidiosis in immunocompentent children. J Clin Pathol. 1985;38:76-81.
10. Baxby D, Hart CA. The incidence of cryptosporidiosis: a two-year prospective survey in a children's hospital. J Hyg (Lond). 1986;96:107-111.
11. Addiss DG, Stewart JM, Finton RJ, et al. Giardia lamblia and Cryptosporidium infections in child day-care centers in Fulton County, Georgia. Pediatr Infect Dis J. 1991;10:907-911.
12. García-Rodríguez JA, Martín-Sánchez AM, Canut Blasco A, et al. The prevalence of Cryptosporidium species in children in day care centres and primary schools in Salamanca (Spain): an epidemiological study. Eur J Epidemiol. 1990;6:432-435.
13. Davies AP, Campbell B, Evans MR, et al. Asymptomatic carriage of protozoan parasites in children in day care centers in the United Kingdom. Pediatr Infect Dis J. 2009;28:838-840.
14. Lacroix C, Berthier M, Agius G, et al. Cryptosporidium oocysts in immunocompetent children: epidemiologic investigations in the day-care centers of Poitiers, France. Eur J Epidemiol. 1987;3:381-385.
15. Sallon S, Deckelbaum RJ, Schmid II, et al. Cryptosporidium, malnutrition, and chronic diarrhea in children. Am J Dis Child. 1988;142:312-315.
16. Sarabia-Arce S, Salazar-Lindo E, Gilman RH, et al. Case-control study of Cryptosporidium parvum infection in Peruvian children hospitalized for diarrhea: possible association with malnutrition and nosocomial infection. Pediatr Infect Dis J. 1990;9:627-631.
17. Lima AA, Fang G, Schorling JB, et al. Persistent diarrhea in Northeast Brazil: etiologies and interactions with malnutrition. Acta Paediatr Suppl. 1992;381:39-44.
18. Mølbak K, Andersen M, Aaby P, et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr. 1997;65:149-152.
19. Checkley W, Epstein LD, Gilman RH, et al. Effects of Cryptosporidium parvum in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol. 1998;148:497-506.
20. Adak GK, Long SM, O'Brien SJ. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut. 2002;51:832-841.
21. Yoder JS, Beach MJ. Centers for Disease Control and Prevention (CDC). Cryptosporidiosis surveillance - United States, 2003-2005. MMWR Surveill Summ. 2007;56:1-10.
22. Yoder JS, Wallace RM, Collier SA, et al; Centers for Disease Control and Prevention (CDC). Cryptosporidiosis surveillance - United States, 2009-2010. MMWR Surveill Summ. 2012;61:1-12.
23. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209-222.
24. Hunter PR, Hughes S, Woodhouse S, et al. Sporadic cryptosporidiosis case-control study with genotyping. Emerg Infect Dis. 2004;10:1241-1249.
25. Chalmers RM, Elwin K, Thomas AL, et al. Long-term Cryptosporidium typing reveals the aetiology and species-specific epidemiology of human cryptosporidiosis in England and Wales, 2000 to 2003. Euro Surveill. 2009;14:19086.
26. Fayer R. General biology. In: Fayer R, Xiao L, eds. Cryptospsoridium and cryptosporidiosis. Boca Raton, FL: CRC Press; 2008:1-42.
27. Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis. 1995;21(suppl 1):S57-S61.
28. Clayton F, Heller T, Kotler DP. Variation in the enteric distribution of cryptosporidia in acquired immunodeficiency syndrome. Am J Clin Path. 1994;102:420-425.
29. Berk RN, Wall SD, McArdle CB, et al. Cryptosporidiosis of the stomach and small intestine in patients with AIDS. AJR Am J Roentgenol. 1984;143:549-554.
30. Meisel JL, Perera DR, Meligro C, et al. Overwhelming watery diarrhea associated with a Cryptosporidium in an immunosuppressed patient. Gastroenterology. 1976;70:1156-1160.
31. Farthing MJ. Clinical aspects of human cryptosporidiosis. In: Petry F, ed. Cryptosporidiosis and microsporidiosis. Contributions in microbiology. Karger, Basel: 2000;6:50-74.
32. Guarino A, Canani RB, Pozio E, et al. Enterotoxic effect of stool supernatant of Cryptosporidium-infected calves on human jejunum. Gastroenterology. 1994;106:28-34.
33. Guarino A, Canani RB, Casola A, et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis. 1995;171:976-983.
34. Laurent F, Eckmann L, Savidge TC, et al. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemikines. Infect Immun. 1997;65:5067-5073.
35. McDonald V, Smith R, Robinson H, et al. Host immune responses against Cryptosporidium. Contrib Microbiol. 2000;6:75-91.
36. Argenzio RA, Liacos JA, Levy ML, et al. Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology. 1990;98:1129-1140.
37. Kirkpatrick BD, Noel F, Rouzier PD, et al. Childhood cryptosporidiosis is associated with a persistent systemic inflammatory response. Clin Infect Dis. 2006;43:604-608.
38. Lumadue JA, Manabe YC, Moore RD, et al. A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS. 1998;12:2459-2466.
39. Bonacini M. Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med. 1992;92:404-411.
40. Benhamou Y, Caumes E, Gerosa Y, et al. AIDS-related cholangiopathy: critical analysis of a prospective series of 26 patients. Dig Dis Sci. 1993;38:1113-1118.
41. Chen XM, Levine SA, Tietz P, et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology. 1998;28:906-913.
42. Chen XM, Gores GJ, Paya CV, et al. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol. 1999;277:G599-G608.
43. Davis JJ, Heyman MB, Ferrell L, et al. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with congenital immunodeficiency disorder. Am J Gastroenterol. 1987;82:1196-1202.
44. Dowsett JF, Miller R, Davidson R, et al. Sclerosing cholangitis in acquired immunodeficiency syndrome: case reports and review of the literature. Scand J Gastroenterol. 1988;23:1267-1274.
45. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med. 1989;86:539-546.
46. Chen XM, LaRusso NF. Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy. Semin Liver Dis. 2002;22:277-289.
47. McLauchlin J, Amar CF, Pedraza-Díaz S, et al. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Infect Dis J. 2003;22:329-335.
48. Clavel A, Arnal AC, Sánchez EC, et al. Respiratory cryptosporidiosis: case series and review of the literature. Infection. 1996;24:341-346.
49. Dunand VA, Hammer SM, Rossi R, et al. Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review. Clin Infect Dis. 1997;25:267-272.
50. Robertson B, Sinclair MI, Forbes AB, et al. Case control studies of sporadic cryptosporidiosis in Melbourne and Adelaide, Australia. Epidemiol Infect. 2002;28:419-431.
51. Pritchard GC, Fleetwood AJ. Cryptosporidiosis and farm visits. Vet Rec. 1995;136:179.
52. Centers for Disease Control and Prevention. Parasites - Cryptosporidium (also known as "Crypto"): Sources of infection and risk factors. April 2015. http://www.cdc.gov (last accessed 11 August 2017).
53. Cordell RL, Addiss DG. Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control. Pediatr Infect Dis J. 1994;13:310-317.
54. Centers for Disease Control and Prevention (CDC). Cryptosporidiosis outbreaks associated with recreational water use - five states, 2006. MMWR Morb Mortal Wkly Rep. 2007;56:729-732.
55. Centers for Disease Control and Prevention (CDC). Outbreak of cryptosporidiosis associated with a splash park - Idaho, 2007. MMWR Morb Mortal Wkly Rep. 2009;58:615-618.
56. Centers for Disease Control and Prevention (CDC). Communitywide cryptosporidiosis outbreak - Utah, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:989-993.
57. MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995;21:57-62.
58. Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med. 1992;116:840-842.
59. Blanshard C, Jackson AM, Shanson DC, et al. Cryptosporidiosis in HIV-seropositive patients. Q J Med. 1992;85:813-823.
60. Navin TR, Weber R, Vugia DJ, et al. Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:154-159.
61. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001 Feb 1;32(3):331-51.
62. Garcia LS. Diagnostic medical parasitology. 5th ed. Washington DC: ASM Press; 2007.
63. Doing KM, Hamm JL, Jellison JA, et al. False-positive results obtained with the Alexon ProSpecT Cryptosporidium enzyme immunoassay. J Clin Microbiol. 1999;37:1582-1583.
64. Public Health Laboratory Service Study Group. Cryptosporidiosis in England and Wales: prevalence and clinical and epidemiological features. BMJ. 1990;300:774-777.
65. Centers for Disease Control and Prevention. Cryptosporidiosis (Cryptosporidium spp.): 2012 case definition. February 2015. http://cdc.gov (last accessed 11 August 2017).
66. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001;184:103-106.
67. Diaz E, Mondragon J, Ramirez E, et al. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg. 2003;68:384-385.
68. Favennec L, Jave Ortiz J, Gargala G, et al. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther. 2003;17:265-270.
69. Doumbo O, Rossignol JF, Pichard E, et al. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg. 1997;56:637-639.
70. Hommer V, Eichholz J, Petry F. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum. J Antimicrob Chemother. 2003;52:359-364.
71. Abdo A, Klassen J, Urbanski S, et al. Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J Hepatol. 2003;38:688-691.
72. Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. December 2016. https://aidsinfo.nih.gov (last accessed 11 August 2017).
73. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. August 2017. http://aidsinfo.nih.gov/ (last accessed 11 August 2017).
74. Rossignol JF, Hidalgo H, Feregrino M, et al. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg. 1998;92:663-666.
75. White AC Jr, Chappell CL, Hayat CS, et al. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis. 1994;170:419-424.
76. Bissuel F, Cotte L, Rabodonirina M, et al. Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis. 1994;18:447-449.
77. Hewitt RG, Yiannoutsos CT, Higgs ES, et al. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. Clin Infect Dis. 2000;31:1084-1092.
78. Kadappu KK, Nagaraja MV, Rao PV, et al. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. J Postgrad Med. 2002;48:179-181.
79. Allam AF, Shehab AY. Efficacy of azithromycin, praziquantel and mirazid in treatment of cryptosporidiosis in school children. J Egypt Soc Parasitol. 2002;32:969-978.
80. Russell TS, Lynch J, Ottolini MG. Eradication of Cryptosporidium in a child undergoing maintenance chemotherapy for leukemia using high dose azithromycin therapy. J Pediatr Hematol Oncol. 1998;20:83-85.
81. Blanshard C, Shanson DC, Gazzard BG. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. Int J STD AIDS. 1997;8:124-129.
82. Palmieri F, Cicalini S, Froio N, et al. Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin. Int J STD AIDS. 2005;16:515-517.
83. Smith NH, Cron NS, Valdez LM, et al. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 1998;178:900-903.
84. Hunter PR, Hughes S, Woodhouse S, et al. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis. 2004;39:504-510.
85. Hay EM, Winfield J, McKendrick MW. Reactive arthritis associated with Cryptosporidium enteritis. Br Med J (Clin Res Ed). 1987;295:248.
86. Ozgül A, Tanyüksel M, Yazicioglu K, et al. Sacroiliitis associated with Cryptosporidium parvum in an HLA-B27-negative patient. Rheumatology. 1999;38:288-289.
87. Cron RQ, Sherry DD. Reiter's syndrome associated with cryptosporidial gastroenteritis. J Rheumatol. 1995;22:1962-1963.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台